EEF1A2 and cancer: First, their differential expression patterns, with eEF1A1 being ubiquitously expressed and eEF1A2 restricted to neurons, muscle, and more frequently overexpressed in cancers, suggest that isoform-specific inhibitors could achieve better therapeutic windows.